1376760-10-9Relevant academic research and scientific papers
PRC1 INHIBITORS AND METHODS OF TREATMENT THEREWITH
-
, (2019/12/28)
Provided herein are small molecule inhibitors of Polycomb Repressive Complex 1 (PRC1) activity, and methods of use thereof for the treatment of disease, including leukemia and other cancers, as well as other diseases dependent on the activity of PRC1.
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Page/Page column 101-102, (2012/05/21)
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
